Multidisciplinary team experienced in creating the platform and applying insights from it to improve treatment of IMIDs.
Founder & Chief Medical Officer Board Director (Vall d’Hebron University Hospital, Professor of Rheumatology UAB)
Founder & Chief Scientific Advisor (HudsonAlpha Institute for Biotechnology, Stanford, UCSF, Harvard University)
Chief Operating Advisor Board Director
(Bay City Capital, Pritzker Consortium, UMICH., U. Copenhagen)
Strategic Business Advisor (Inivata, Personalized Medicine Partners, GSK, Organon Teknika)